Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RAPTIVA (efalizumab)

William Abramovits1

  • 1Southwestern Medical School, Dallas, TX.

Skinmed
|January 16, 2004
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and Patient Experiences in a WhatsApp-Based Educational Pilot for Spanish-Speaking Adults With Chronic Spontaneous Urticaria.

International journal of dermatology·2026
Same author

Zelsuvmi<sup>TM</sup> (Berdazimer) Topical Gel.

Skinmed·2025
Same author

Filsuvez<sup>®</sup> (Birch Triterpenes) Topical Gel.

Skinmed·2025
Same author

BIMZELX<sup>®</sup> (Bimekizumab-bkzx) Injection, for Subcutaneous Use.

Skinmed·2024
Same author

CABTREO<sup>TM</sup> (Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide) Topical Gel.

Skinmed·2024
Same author

Animal Signs in Dermatology: A Furry Approach to Remembering Various Dermatologic Conditions.

Skinmed·2024
Same journal

Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Fenofibrate Lipid Lowering Agent.

Skinmed·2025
Same journal

Racial Disparities in the Management of Atopic Dermatitis: An Analysis of the National Ambulatory Medical Care Survey, 2012-2018.

Skinmed·2025
Same journal

"Pseudo-Chik Sign" Following COVID-19: Pigmentation Hitherto Unreported.

Skinmed·2025
Same journal

Hyperpigmented Scaly Lesions in the Axillae.

Skinmed·2025
Same journal

Sweet Syndrome-Like Disorder Induced by the Oxford-AstraZeneca<sup>®</sup> SARS-CoV-2 Vaccine.

Skinmed·2025
Same journal

Lockdown Lessons from Dermatology Consultations during the COVID-19 Pandemic in a Tertiary Care Center.

Skinmed·2025
See all related articles